Source: Journal of Clinical Oncology. Conference titles: Annual Meeting of the American Society of Clinical Oncology. Unidade: FM
Subjects: QUALIDADE DE VIDA, NEOPLASIAS COLORRETAIS, RESUMOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGALLA, J et al. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 out. 2024. , 2005APA
Segalla, J., Eyll, B. van, Federico, M., Perdicaris, M., Cabral, S., Skare, N., et al. (2005). Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Segalla J, Eyll B van, Federico M, Perdicaris M, Cabral S, Skare N, saltz E, Moura G, Filho U, Franke F. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. 2005 ; 23( 16S ): 751s.[citado 2024 out. 17 ]Vancouver
Segalla J, Eyll B van, Federico M, Perdicaris M, Cabral S, Skare N, saltz E, Moura G, Filho U, Franke F. Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X). Journal of Clinical Oncology. 2005 ; 23( 16S ): 751s.[citado 2024 out. 17 ]